You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

CEO grows stake in Bulgarian drug maker Sopharma

Author Mario Tanev
CEO grows stake in Bulgarian drug maker Sopharma Sopharma/ All rights reserved

SOFIA (Bulgaria), December 6 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its CEO Ognyan Donev has acquired 10,189 shares in the company at a weighted average price per share of 3.4478 levs ($1.96/1.76 euro).

Donev acquired the shares through deals on the Bulgarian Stock Exchange on December 5, Sopharma said in a bourse filing.

The 23,771 shares are equal to a 0.0076% stake in Sopharma.

At the end of September, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.

However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.

As at 12:40 CET on Friday, Sopharma shares traded 0.58% lower at 3.43 levs on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)